Two-photon Fluorescence Microscopy of Dermatologic Biopsies
Part of paid clinical trials in Victor, New York.
- Sponsor
- University of Rochester
- Study ID
- NCT07773688
- Status
- Recruiting
Conditions
- Basal Cell Carcinoma of Skin
- Melanocytic Lesion, Adult
- Squamous Cell Carcinoma
Eligibility Criteria
- Sex
- ALL
- Age
- N/A - N/A
- Healthy Volunteers
- Not accepted
Interventions
- Two photon microscopy imaging — DEVICEEx vivo tissues will be imaged with two photon microscopy
Study Details
The goal of this study is to investigate the ability of two-photon fluorescence microscopy to evaluate dermatologic biopsies. The main questions it aims to answer are: • How well do two-photon fluorescence images of biopsies taken in a clinic and evaluated by a pathologist agree with conventional histology?
Key Dates
- First listed
- Aug 19, 2026
- Start date
- Jun 1, 2026
- Status verified
- Aug 2026
- Primary completion
- Apr 30, 2028
- Completion
- Apr 30, 2028
Study Design
- Enrollment
- 644 participants (estimated)
- Allocation
- NA
- Intervention model
- SINGLE_GROUP
- Primary purpose
- DIAGNOSTIC
Arms
- Experimental: TPFM imaging of biopsySpecimens will be imaged with TPFM
Primary Outcome Measure
Specificity of TPFM for prediction of the official patient diagnoses [ Time Frame: After completion of patient diagnosis (typically 1-2 weeks after procedure) ]
Central Contacts
- Michael G Giacomelli, Ph.D5852766260
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Rochester Dermatologic Surgery | Victor | New York | 14654 |
Find similar trials in Victor, NY
By condition
By specialty
By research site
Related Studies
- Raman Spectroscopy and Skin CancerRecruiting · Tiezhi Zhang · Stony Brook, New York
- Alpha Radiation Emitters Device (DaRT) for the Treatment of Cutaneous SCC for Immunocompromised PatientsRecruiting · Alpha Tau Medical LTD. · Gilbert, Arizona
- Treating Basal and Squamous Cell Carcinomas With Fractional Laser and Tirbanibulin OintmentPHASE1/PHASE2 · Recruiting · Bruce Robinson, MD · New York, New York
- Defining TRPV4 Contribution of Schwann Cells to Oral Cancer PainRecruiting · New York University · New York, New York